QTTB Q1 2019 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$270,000-67.2% YoY

Gross Profit

$00.0% margin

Operating Income

-$25M-9304.8% margin

Net Income

-$24M-8834.1% margin

EPS (Diluted)

$-11.48

QoQ Revenue Growth

-72.4%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$233M

Total Liabilities

$59M

Stockholders' Equity

$174M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$270,000	$823,372	-67.2%
Gross Profit	$0	$602,776	-100.0%
Operating Income	-$25M	-$11M	-128.3%
Net Income	-$24M	-$11M	-126.7%